Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minhang Xin

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Bioorganic & Medicinal Chemistry Letters|November 2, 2013
The discovery of novel N-(2-pyrimidinylamino) benzamide derivatives as potent hedgehog signaling pathway inhibitorsMinhang Xin, Jun Wen, Feng Tang, et al.
Bioorganic & Medicinal Chemistry|October 11, 2025
Synthesis and degradation effect of PROTACs targeting EGFR triple mutantsXiao-Xiao Xi, Hong-Yi Zhao, Minhang Xin, et al.
Medicinal Research Reviews|January 10, 2018
Strategies to target the Hedgehog signaling pathway for cancer therapyMinhang Xin, Xinyue Ji, Ladie Kimberly De La Cruz, et al.
Bioorganic & Medicinal Chemistry|August 23, 2019
Synthesis and biological evaluation of 4-(piperid-3-yl)amino substituted 6-pyridylquinazolines as potent PI3Kδ inhibitorsYifan Feng, Weiming Duan, Shu Fan, et al.
Nature Biomedical Engineering|July 1, 2024
Cell-drug conjugatesYanfang Wang, Jiaqi Shi, Minhang Xin, et al.
Expert Opinion on Therapeutic Patents|February 24, 2022
Menin-MLL protein-protein interaction inhibitors: a patent review (2014-2021)Huanrong Bai, San-Qi Zhang, Hao Lei, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2017
Introduction of fluorine to phenyl group of 4-(2-pyrimidinylamino)benzamides leading to a series of potent hedgehog signaling pathway inhibitorsMinhang Xin, Liandi Zhang, Jun Wen, et al.
European Journal of Medicinal Chemistry|April 10, 2018
The development of Bruton's tyrosine kinase (BTK) inhibitors from 2012 to 2017: A mini-reviewChengyuan Liang, Danni Tian, Xiaodong Ren, et al.
Future Medicinal Chemistry|October 5, 2020
Design and synthesis of novel phthalazinone derivatives as potent poly(ADP-ribose)polymerase 1 inhibitorsMinhang Xin, Jiajia Sun, Wei Huang, et al.
European Journal of Medicinal Chemistry|October 15, 2023
Modification of osimertinib to discover new potent EGFR<sup>C797S</sup>-TK inhibitorsXiao-Xiao Xi, Hong-Yi Zhao, Yu-Ze Mao, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry Letters|November 2, 2013
The discovery of novel N-(2-pyrimidinylamino) benzamide derivatives as potent hedgehog signaling pathway inhibitorsMinhang Xin, Jun Wen, Feng Tang, et al.
Bioorganic & Medicinal Chemistry|October 11, 2025
Synthesis and degradation effect of PROTACs targeting EGFR triple mutantsXiao-Xiao Xi, Hong-Yi Zhao, Minhang Xin, et al.
Medicinal Research Reviews|January 10, 2018
Strategies to target the Hedgehog signaling pathway for cancer therapyMinhang Xin, Xinyue Ji, Ladie Kimberly De La Cruz, et al.
Bioorganic & Medicinal Chemistry|August 23, 2019
Synthesis and biological evaluation of 4-(piperid-3-yl)amino substituted 6-pyridylquinazolines as potent PI3Kδ inhibitorsYifan Feng, Weiming Duan, Shu Fan, et al.
Nature Biomedical Engineering|July 1, 2024
Cell-drug conjugatesYanfang Wang, Jiaqi Shi, Minhang Xin, et al.
Expert Opinion on Therapeutic Patents|February 24, 2022
Menin-MLL protein-protein interaction inhibitors: a patent review (2014-2021)Huanrong Bai, San-Qi Zhang, Hao Lei, et al.
Bioorganic & Medicinal Chemistry Letters|June 24, 2017
Introduction of fluorine to phenyl group of 4-(2-pyrimidinylamino)benzamides leading to a series of potent hedgehog signaling pathway inhibitorsMinhang Xin, Liandi Zhang, Jun Wen, et al.
European Journal of Medicinal Chemistry|April 10, 2018
The development of Bruton's tyrosine kinase (BTK) inhibitors from 2012 to 2017: A mini-reviewChengyuan Liang, Danni Tian, Xiaodong Ren, et al.
Future Medicinal Chemistry|October 5, 2020
Design and synthesis of novel phthalazinone derivatives as potent poly(ADP-ribose)polymerase 1 inhibitorsMinhang Xin, Jiajia Sun, Wei Huang, et al.
European Journal of Medicinal Chemistry|October 15, 2023
Modification of osimertinib to discover new potent EGFR<sup>C797S</sup>-TK inhibitorsXiao-Xiao Xi, Hong-Yi Zhao, Yu-Ze Mao, et al.
Pageof 7